symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
GTHR,0.006,0.829588,5434,212000,0,0.004-0.0367,0.0005,"GeneThera, Inc.",USD,0001017110,US37185E3062,37185E306,Other OTC,PNK,Biotechnology,https://www.genethera.net,"GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of zoonotic diseases. It offers treatments for zoonotic diseases, such as COVID -19 disease; paratuberculosis (Johne's disease) that is in Stage III clinical phase; mad cow and chronic wasting diseases; and E.coli and salmonella infections, as well as develops vaccine for mycobacterium avium sub paratuberculosis bacteria. The company's Molecular Robotic/AI Platform and Therapeutic strategy is designed to prevent the spread of disease from animals and allow to better control of zoonotic infectious agents. GeneThera, Inc. is based in Westminster, Colorado.","Dr. Antonio  Milici M.D., Ph.D.",Healthcare,US,2,720 587 5100,3051 West 105th Avenue,Westminster,CO,80035,,0,https://financialmodelingprep.com/image-stock/GTHR.png,2012-09-25,False,False,False,False,False
